Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia
- 15 January 2005
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 57 (2) , 155-161
- https://doi.org/10.1016/j.biopsych.2004.10.017
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Glucocorticoid‐induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobeEuropean Journal of Neuroscience, 2003
- The Stress Cascade and Schizophrenia: Etiology and OnsetSchizophrenia Bulletin, 2003
- An open label trial of C-1073 (mifepristone) for psychotic major depression*Biological Psychiatry, 2002
- Rapid Reversal of Psychotic Depression Using MifepristoneJournal of Clinical Psychopharmacology, 2001
- The neuropsychology and neuroanatomy of bipolar affective disorder: a critical reviewBipolar Disorders, 2001
- Mood and Cognitive Changes During Systemic Corticosteroid TherapyThe Primary Care Companion For CNS Disorders, 2001
- Acute cortisone administration impairs retrieval of long-term declarative memory in humansNature Neuroscience, 2000
- Verbal Working Memory Impairment in Schizophrenia Patients and Their First-Degree Relatives: Evidence From the Digit Span TaskAmerican Journal of Psychiatry, 2000
- Cognitive Impairment in Schizophrenia Is the Core of the DisorderCritical Reviews™ in Neurobiology, 2000
- Depression in schizophrenia: a comparison of three measuresSchizophrenia Research, 1996